Ausgabe 3/2002
Inhalt (8 Artikel)
Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapy
Jan Lehmann, Margitta Retz, Michael Stöckle
Advanced bladder cancer...Where are we now and where are we going?
Michael F. Sarosdy, Stefan Machtens
The role of chemotherapy and radiation in organ-preservation strategies for muscle-invasive bladder cancer
Brian A. Bradley, Zev Wajsman
New drugs and new approaches for the treatment of metastatic urothelial cancer
Fabio Calabrò, Cora N. Sternberg
Surgical bladder preserving strategies in the treatment of muscle-invasive bladder cancer
M. Kuczyk, S. Machtens, C. Bokemeyer, C. Kollmannsberger, J. Hartmann, M. Kondoh, A. Merseburger, U. Jonas
Prognostic markers in muscle invasive bladder cancer
Rabi Tiguert, Annie Lessard, Alan So, Yves Fradet
Management of locally advanced bladder cancer: early vs deferred chemotherapy
Samira Syed, Geoffrey R. Weiss